Twice daily dosing of dabigatran for stroke prevention in atrial fibrillation: a pharmacokinetic justification

Author： Clemens Andreas   Haertter Sebastian   Friedman Jeffrey   Brueckmann Martina   Stangier Joachim   van Ryn Joanne   Lehr Thorsten  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.28, Iss.2, 2012-02, pp. : 195-201

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ximelagatran for stroke prevention in atrial fibrillation

By Salam Amar M  

Therapy, Vol. 1, Iss. 1, 2004-09 ,pp. : 49-52

Future Medicine

Access to resources Recommend Favorite

Better prevention of stroke through screening for atrial fibrillation

By James Martin A   Campbell John L  

British Journal of General Practice, Vol. 62, Iss. 598, 2012-05 ,pp. : 234-235

Royal College of General Practitioners

Access to resources Recommend Favorite

Low cefpirome levels during twice daily dosing in critically ill septic patients: pharmacokinetic modelling calls for more frequent dosing

By Lipman Jeffrey   Wallis Steven C.   Rickard Claire M.   Fraenkel David  

Intensive Care Medicine, Vol. 27, Iss. 2, 2001-02 ,pp. : 363-370

Springer Publishing Company

Access to resources Recommend Favorite

Stroke prevention with rivaroxaban in higher‐risk populations with atrial fibrillation

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 7, 2015-07 ,pp. : 743-756

John Wiley & Sons Inc

Access to resources Recommend Favorite

Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: indications diversity and future perspectives

By  

Continuing Cardiology Education, Vol. 2, Iss. 1, 2016-03 ,pp. : 32-36

John Wiley & Sons Inc

Access to resources Recommend Favorite